Prolonged activation of NF-κB following traumatic brain injury in rats

Journal of Neurotrauma

Volumn 16, Issue 11, 1999, Pages 1023-1034

  Nonaka, Masahiro ^a   Chen, Xiao Han ^a   Pierce, Jean E S ^a   Leoni, Matthew J ^a   McIntosh, Tracy K ^a   Wolf, John A ^a   Smith, Douglas H ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain atrophy; Inflammation; NF B, p65; Traumatic brain injury

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN INJURY; BRAIN VENTRICLE; CELL NUCLEUS; CYTOSOL; ENCEPHALITIS; ENDOTHELIUM CELL; MACROPHAGE; MALE; MICROGLIA; NERVE DEGENERATION; NERVE FIBER; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RAT;

EID: 0032739937     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1999.16.1023     Document Type: Article

References (70)

1. BAEUERLE, P.A., and BALTIMORE, D. (1988). IκB: a specific inhibitor of the NF-κB transcription factor. Science 242, 540-546.
2. BAEUERLE, P.A., and HENKEL, T. (1994). Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179.
3. BARGER, S.W., and HARMON, A.D. (1997). Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388, 878-881.
4. BETHEA, J.R., CASTRO, M., KEANE, R.W., LEE, T.T., DIETRICH, W.D., and YEZIERSKI, R.P. (1998). Traumatic spinal cord injury induces nuclear factor κB activation. J. Neurosci. 18, 3251-3260.
5. BRAND, K., PAGE, S., ROGLER, G., et al. (1996). Activated transcription factor nuclear factor kappa B is present in the atherosclerotic lesion. J. Clin. Invest. 97, 1715-1722.
6. BREITNER, J.C., GAU, B.A., WELSH, K.A., et al. (1994). Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 44, 227-232.
7. CARLOS, T.M., CLARK, R.S., FRANICOLA-HIGGINS, D., SCHIDING, J.K., and KOCHANEK, P.M. (1997). Expression of endothelial adhesion molecules and recruitment of neutrophils after traumatic brain injury in rats. J. Leukoc. Biol. 61, 279-285.
8. CLARK, R.S., SCHIDING, J.K., KACZOROWSKI, S.L., MARION, D.W., and KOCHANEK, P.M. (1994). Neutrophil accumulation after traumatic brain injury: comparison of weight drop and controlled cortical impact models. J. Neurotrauma 11, 499-506.
9. CLEMENS, J.A., STEPHENSON, D.T., DIXON, E.P., et al. (1997). Global cerebral ischemia activates nuclear factor kappa B prior to evidence of DNA fragmentation. Mol. Brain Res. 48, 187-196.
10. CYBULSKY, M.I., and GIMBRONE, M.A.J. (1991). Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788-791.
11. DIXON, C.E., KOCHANEK, P.M., YAN, H.Q., et al. (1999). One-year study of spatial memory, brain morphology, and cholinergic markers after moderate controlled cortical impact in rats. J. Neurotrauma 16, 109-122.
12. ERNST, M.K., DUNN, L.L., and RICE, N.R. (1995). The PEST-like sequence of IκBα is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or Re1A homodimers. Mol. Cell. Biol. 15, 872-882.
13. FAN, L., YOUNG, P.R., BARONE, F.C., et al. (1995). Experimental brain injury induces expression of interleukin-1β mRNA in the rat brain. Mol. Res. 30, 125-130.
14. FAN, L., YOUNG, P.R., BARONE, F.C., FEUERSTEIN, G.Z., SMITH, D.H., and McINTOSH, T.K. (1996). Experimental brain injury induces differential expression of tumor necrosis factor-α mRNA in the CNS. Mol. Brain Res. 36, 287-291.
15. FEUERSTEIN, G.Z., LIU, T., and BARONE, F.C. (1994). Cytokines, inflammation, and brain injury: role of tumor necrosis factor-α. Cerebrovasc. Brain Metab. Rev. 6, 341-360.
16. GHIRNIKAR, R.S., LEE, Y.L., HE, T.R., and ENG, L.F. (1996). Chemokine expression in rat stab wound brain injury. J. Neurosci. Res. 46, 727-733.
17. GLABINSKI, A.R., BALASINGAM, V., TANI, M., et al. (1996). Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J. Immunol. 156, 4363-4368.
18. GRILLI, M., PIZZI, M., MEMO, M., and SPANO, P. (1996). Neuroprotection by aspirin and sodium salicylate through blockade NF-κB activation. Science 274, 1383-1385.
19. GRZYBICKI, D., MOORE, S.A., SCHELPER, R., GLABINSKI, A.R., RANSOHOFF, R.M., and MURPHY, S. (1998). Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma. Acta Neuropathol. (Berl.) 95, 98-103.
20. GVERIC, D., KALTSCHMIDT, C., CUZNER, M.L., and NEWCOMBE, J. (1999). Transcription factor NF-κB and inhibitor IκBα are localized in macrophages in active multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 57, 168-178.
21. HOLMIN, S., MATHIESEN, T., SHETYE, J., and BIBERFELD, P. (1995). Intracerebral inflammatory response to experimental brain contusion. Acta Neurochir. 132, 110-119.
22. HUNOT, S., BRUGG, B., RICARD, D., et al. (1997). Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 94, 7531-7536.
23. IADEMARCO, M.F., McQUILLAN, J.J., ROSEN, G.D., and DEAN, D.C. (1992). Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267, 16323-16329.
24. KALTSCHMIDT, B., BAEUERLE, P.A., and KALTSCHMIDT, C. (1993). Potential involvement of the transcription factor NF-κB in neurological disorders. Mol. Aspects Med. 14, 171-190.
25. KALTSCHMIDT, B., UHEREK, M., VOLK, B., BAEUERLE, P.A., and KALTSCHMIDT, C. (1997). Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94, 2642-2647.
26. KALTSCHMIDT, C., KALTSCHMIDT, B., and BAEUERLE, P.A. (1993). Brain synapses contain inducible forms of the transcription factor NF-κB. Mech. Dev. 43, 135-147.
27. KALTSCHMIDT, C., KALTSCHMIDT, B., and BAEUERLE, P.A. (1995a). Stimulation of ionotropic glutamate receptors activates transcription factor NF-κB in primary neurons. Proc. Natl. Acad. Sci. U.S.A. 92, 9618-9622.
28. KALTSCHMIDT, C., KALTSCHMIDT, B., HENKEL, T., STOCKINGER, H., and BAEUERLE, P.A. (1995b). Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol. Chem. Hoppe Seyle 376, 9-16.
29. KALTSCHMIDT, C., KALTSCHMIDT, B., LANNESVIEIRA, J., KREUTZBERG, G.W., WEKERLE, H., and BAEUERLE, P.A. (1994). Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 55, 99-106.
30. KNOBLACH, S.M., and FADEN, A.I. (1998). Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp. Neurol. 153, 143-151.
31. KOCHANEK, P.M., and HALLENBECK, J.M. (1992). Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23, 1367-1379.
32. KOPP, E., and GHOSH, S. (1994). Inhibition of NF-κB by sodium salicylate and aspirin. Science 265, 956-959.
33. KOSSMANN, T., STAHEL, P.F., LENZLINGER, P.M., et al. (1997). Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dys-function and nerve growth factor production. J. Cereb. Blood Flow Metab. 17, 280-289.
34. LEDEBUR, H.C., and PARKS, T.P. (1995). Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-κB site and p65 homodimers. J. Biol. Chem. 270, 933-943.
35. LENARDO, M.J., and BALTIMORE, D. (1989). NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58, 227-229.
36. LEZOUALC'H, F., SAGARA, Y., HOLSBOER, F., and BEHL, C. (1998). High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells. J. Neurosci. 18, 3224-3232.
37. MATTSON, M.P., GOODMAN, H.M., LUO, H., FU, W., and FURUKAWA, K. (1997). Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681-697.
38. McINTOSH, T.K., VINK, R., NOBLE, L., YAMAKAMI, I., FERNYAK, S., and FADEN, A.I. (1989). Traumatic brain injury in the rat: characterization of a lateral fluid percussion model. Neuroscience 28, 233-244.
39. MORTIMER, J.A., VAN DUIJN, C.M., CHANDRA, L., et al. (1991). Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20, S28-S35.
40. O'NEILL, L.A., and KALTSCHMIDT, C. (1997a). NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252-258.
41. O'NEILL, L.A, and KALTSCHMIDT, C. (1997b). NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252-258.
42. OSBORN, L., KUNKEL, S., and NABEL, G.J. (1989). Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. U.S.A. 86, 2336-2340.
43. PAHL, H.L., and BAEUERLE, P.A. (1997). The ER-overload response: activation of NF-κB. Trends Biochem. Sci. 22, 63-67.
44. PIERCE, J.E.S., SMITH, D.H., TROJANOWSKI, J.Q., and McINTOSH, T.K. (1988). Enduring cognitive, neurobehavioral, and histopathological changes persist for up to one year following severe experimental brain injury in rats. Neuroscience 87, 359-369.
45. PIERCE, J.E.S., TROJANOWSKI, J.Q., GRAHAM, D.I., SMITH, D.H., and McINTOSH, T.K. (1996). Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and amyloid β peptide following experimental brain injury in the rat. J. Neurosci. 16, 1083-1090.
46. POVELONES, M., TRAN, K., THANOS, D., and AMBRON, R.T. (1997). An NF-κB-like transcription factor in axoplasm is rapidly inactivated after nerve injury in aplysia. J. Neurosci. 17, 4915-4920.
47. POVLISHOCK, J.T., and CHRISTMAN, C.W. (1995). The pathobiology of traumatically induced axonal injury in animals and humans: a review of current thoughts. J. Neurotrauma 12, 555-564.
48. QIN, Z.H., WANG, Y., NAKAI, M., and CHASE, T.N. (1998). Nuclear factor kappa B contributes to excitotoxin-induced apoptosis in rat striatum. Mol. Pharm. 53, 33-42.
49. RICH, J.B., RASMUSSON, D.X., FOLSTEIN, M.F., CARSON, K.A., KAWAS, C., and BRANDT, J. (1995). Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45, 51-55.
50. RIMANIOL, A.C., LEKIEFFRE, D., SERRANO, A., MASSON, A., BENAVIDES, J., and ZAVALA, F. (1995). Biphasic transforming growth factor beta production flanking the pro-inflammatory cytokine response in cerebral trauma. Neuroreport 7, 133-136.
51. ROBERTS, G.W., GENTLEMAN, S.M., LYNCH, A., and GRAHAM, D.I. (1991). βA4 amyloid protein deposition in brain after head trauma. Lancet 338, 1422-1423.
52. ROBERTS, G.W., GENTLEMAN, S.M., LYNCH, A., MURRAY, L., LANDON, M., and GRAHAM, D.I. (1994). β amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 57, 419-425.
53. RODRIGUEZ, M.S., MICHALOPOULOS, I., ARENZANASEISDEDOS, F., and HAY, R.T. (1999). Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein. Mol. Cell. Biol. 15, 2413-2419.
54. ROTHWELL, N.J., ALLAN, S., and TOULMOND, S. (1997). The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J. Clin. Invest. 100, 2648-2652.
55. SCHEINMAN, R.I., COGSWELL, P.C., LOFQUIST, A.K., and BALDWIN, A.S.J. (1995). Role of transcriptional activation of IκB α in mediation of immunosuppression by glucocorticoids. Science 270, 286.
56. SCHMIDT, K.N., AMSTAD, P.A., CERUTTI, P.A., and BAEUERLE, P.A. (1995). The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB. Chem. Biol. 2, 13-22.
57. SEN, R., and BALTIMORE, D. (1986). Multiple nuclear factors interact with the immunoglobulin enhancer sequence. Cell 46, 705-716.
58. SHOHAMI, E., GALLILY, R., MECHOULAM, R., BASS, R., and BEN-HUR, T. (1997). Cytokine production in the brain following closed head injury: dexanabinol (HU211) is a novel TNF alpha inhibitor and an effective neuroprotectant. J. Neuroimmunol. 72, 169-177.
59. SMITH, D.H., CHEN, X.-H., PIERCE, J.E.S., et al. (1997a). Progressive atrophy and neuronal death for one year following brain trauma in the rat. J. Neurotrauma 14, 715-727.
60. SMITH, D.H., CHEN, X.-H., XU, B.-N., McINTOSH, T.K., GENNARELLI, T.A., and MEANEY, D.F. (1997b). Characterization of diffuse axonal pathology and selective hippocampal damage following inertial brain trauma in the pig. J. Neuropathol. Exp. Neurol. 56, 822-834.
61. SOARES, H.D., HICKS, R.R., SMITH, D.H., and McINTOSH, T.K. (1995). Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J. Neurosci. 15, 8223-8233.
62. STEWART, W.F., KAWAS, C., CORRADA, M., and METTER, E.J. (1997). Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626-632.
63. TAUPIN, V., TOULMOND, S., SERRANO, A., BENAVIDES, J., and ZAVALA, F. (1993). Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro54864, a peripheral-type (p site) benzodiazepine ligand. J. Neuroimmunol. 42, 177-186.
64. TERAI, K., MATSUO, A., and McGEER, P.L. (1996). Enhancement of immunoreactivity for NF-κB in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res. 735, 159-168.
65. TOGASHI, H., SASAKI, M., FROHMAN, E., et al. (1997). Neuronal (type I) nitric oxide synthase regulates nuclear factor kappa B activity and immunologic (type II) nitric oxide synthase expression. Proc. Natl. Acad. Sci. U.S.A. 94, 2676-2680.
66. TOULMOND, S., PARNET, P., and LINTHORST, A.C.E. (1996). When cytokines get on your nerves: cytokine networks and CNS pathologies. Trends Neurosci. 19, 409-410.
67. UEDA, A., ISHIGATSUBO, Y., OKUBO, T., and YOSHIMURA, T. (1997). Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-κB sites and NF-κB/Rel subunit specificity. J. Biol. Chem. 272, 31092-31099.
68. WHALEN, M.J., CARLOS, T.M., KOCHANEK, P.M., and HEINEMANN, S. (1998). Blood-brain barrier permeability, neutrophil accumulation and vascular adhesion molecule expression after controlled cortical impact in rats. A preliminary study. Acta Neurochir. Suppl. 71, 212-214.
69. XIE, Q.W., KASHIWABARA, Y., and NATHAN, C. (1994). Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269, 4705-1708.
70. YANG, K., MU, X.S., and HAYES, R.L. (1995). Increased cortical nuclear factor κB (NF-κB) DNA binding activity after traumatic brain injury in rats. Neurosci. Lett. 197, 101-104.